CliffBio

Jazz Pharmaceuticals

Patent cliffs & loss of exclusivity

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. DEFITELIODEFIBROTIDE SODIUMSmall mol.Jun 2032
  2. VYXEOSCYTARABINE; DAUNORUBICINSmall mol.Apr 2033
  3. XYREMSODIUM OXYBATESmall mol.Sep 2033
  4. LUVOX CRFLUVOXAMINE MALEATESmall mol.—
  5. LUVOX CRFLUVOXAMINE MALEATESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.